Condition: Rheumatoid Arthritis (RA) · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants with rheumatoid arthritis (RA). The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study will last approximately 33 weeks excluding screening.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | Recruiting |
| Arizona Research Center | Phoenix, Arizona, United States | Recruiting |
| Clinical Research of West Florida, Inc. (Clearwater) | Clearwater, Florida, United States | Recruiting |
| GNP Research at Mark Jaffe, MD | Cooper City, Florida, United States | Recruiting |
| Fortrea Clinical Research Unit | Daytona Beach, Florida, United States | Recruiting |
| AGA Clinical Trials | Hialeah, Florida, United States | Recruiting |
| Advanced Pharma CR, LLC | Miami, Florida, United States | Recruiting |
| Floridian Clinical Research | Miami Lakes, Florida, United States | Recruiting |
| Oasis Clinical Research | Las Vegas, Nevada, United States | Recruiting |
| Universitätsklinikum Charité | Berlin, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07258849